Sources Sought Notice to obtain a fully automated digital cytology system for Brooke Army Medical Center (BAMC) Department of Pathology and Area Laboratory Services Cytology Laboratory, Fort Sam Houston, Texas.

SOL #: 3-31-2026Sources Sought

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRC0 WEST
JBSA FT SAM HOUSTON, TX, 78234-4504, United States

Place of Performance

DWG, TX

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 31, 2026
2
Response Deadline
Apr 14, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Medical Readiness Contracting Office West (MRCO-W) is conducting a Sources Sought Notice to identify potential vendors for a fully automated digital cytology system for Brooke Army Medical Center (BAMC) Department of Pathology and Area Laboratory Services Cytology Laboratory at Fort Sam Houston, Texas. This requirement is for the Hologic Genius® Digital Diagnostics System, which combines AI with advanced volumetric imaging to detect precancerous lesions and cervical cancer cells. Responses are due by April 14, 2026, at 4:00 PM CST.

Scope of Work

BAMC requires a comprehensive digital cytology and digital pathology workflow solution. The system must include the Hologic Genius® Digital Diagnostics System, comprising the Genius™ Digital Imager, Genius™ Image Management Server (IMS), Genius™ Review Station, and Genius™ Cervical AI software. Key components and quantities identified include:

  • Genius Digital Diagnostics Imager: 3 units
  • Display, 27IN, 8MP: 17 units
  • Assembly, Genius Image Management Server: 1 unit
  • ASSY, MAIN, REVIEW SCOPE MANUAL: 1 unit

The vendor will provide the lease, installation, configuration, validation, and maintenance for these components. The Genius™ Cervical AI is an FDA-cleared algorithm for comprehensive digital cytology analysis on ThinPrep® Pap Test slides, automatically detecting clinically significant findings and prioritizing suspicious fields. The Genius™ Digital Imager converts slides into high-resolution, all-in-focus digital images with a 400-slide capacity. The anticipated workload for 'THIN PREP PAP TEST WITH GENIUS USAGE FEE' is 55,000 tests annually for the base year and each of the four option periods.

Contract & Timeline

  • Type: Sources Sought Notice (not a solicitation)
  • NAICS: 325413 (In-Vitro Diagnostic Substance Manufacturing)
  • Performance Period: October 1, 2026, through September 30, 2031 (base period)
  • Set-Aside: None specified (market research stage)
  • Response Due: April 14, 2026, 4:00 PM CST
  • Published: March 31, 2026

Submission Requirements

Interested parties should submit:

  1. Company Information: Name, CAGE code, point of contact (phone, email), and socio-economic category (e.g., 8(a), HUBZone, WOSB, SDVOSB, Small, Other-than-Small).
  2. Capability Statement: Limited to ten pages, describing how the company meets the objectives, with proof such as FDA approval. This should address the provision of all necessary components, 5 years of FDA field action notifications, Genius™ Cervical AI, Genius™ Digital Imager, Genius™ Review Station, Genius™ Image Management Server, a manual review microscope, software revisions/updates, replacement of worn/defective parts, and emergency order delivery capabilities.

Additional Notes

This notice is for information and planning purposes only and does not constitute a solicitation. The government will use responses to formulate its acquisition strategy. Failure to receive sufficient competitive information may lead to a sole-source contract. All information submitted is voluntary, and the government will not pay for costs incurred. Not responding does not preclude participation in any future solicitation. Questions must be submitted via email to Medina L. Woodson (medina.l.woodson.civ@health.mil) and Salameya Paulouskaya (salameya.paulouskaya2.civ@health.mil).

People

Points of Contact

Medina L. WoodsonPRIMARY
Salameya PaulouskayaSECONDARY

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: Mar 31, 2026